Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,017 | 548 | 99.5% |
| Education | $41.18 | 5 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,261 | 95 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $773.33 | 55 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $590.38 | 47 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $472.89 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $360.50 | 24 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $345.72 | 29 | $0 (2024) |
| Allergan, Inc. | $324.78 | 26 | $0 (2020) |
| Merck Sharp & Dohme LLC | $319.35 | 25 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $313.50 | 17 | $0 (2024) |
| Lilly USA, LLC | $288.81 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,758 | 102 | Novo Nordisk Inc ($304.46) |
| 2023 | $1,136 | 74 | Novo Nordisk Inc ($144.19) |
| 2022 | $615.22 | 39 | Novo Nordisk Inc ($70.79) |
| 2020 | $151.38 | 11 | Boehringer Ingelheim Pharmaceuticals, Inc. ($27.13) |
| 2019 | $1,346 | 107 | Novo Nordisk Inc ($331.27) |
| 2018 | $1,305 | 102 | Novo Nordisk Inc ($219.39) |
| 2017 | $1,747 | 118 | SANOFI-AVENTIS U.S. LLC ($223.55) |
All Payment Transactions
553 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/17/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $34.63 | General |
| Category: Oncology | ||||||
| 12/04/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/03/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 11/27/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $20.89 | General |
| Category: Cardio-renal | ||||||
| 11/26/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: VACCINES | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.13 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | Merck Sharp & Dohme LLC | LAGEVRIO (Drug) | Food and Beverage | In-kind items and services | $17.08 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 11/07/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: Respiratory | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: Gastroenterology | ||||||
| 10/23/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $4.90 | General |
| Category: Gastroenterology | ||||||
| 10/22/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $18.27 | General |
| Category: PSYCHIATRY | ||||||
| 10/17/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: Biological | ||||||
| 10/16/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Cardio-renal | ||||||
| 10/15/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $16.44 | General |
| 10/14/2024 | MITSUBISHI TANABE PHARMA AMERICA, INC. | RADICAVA (Drug), RADICAVA ORS | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: AMYOTROPHIC LATERAL SCLEROSIS | ||||||
| 10/09/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.12 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Neuroscience | ||||||
| 10/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Gastroenterology | ||||||
| 09/27/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.09 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.09 | General |
| 09/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $33.10 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,115 | 2,001 | $613,072 | $183,125 |
| 2022 | 18 | 1,188 | 2,373 | $711,418 | $202,439 |
| 2021 | 20 | 977 | 2,299 | $681,544 | $193,055 |
| 2020 | 21 | 1,165 | 2,335 | $657,743 | $174,908 |
All Medicare Procedures & Services
76 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 85 | 85 | $2,975 | $2,864 | 96.3% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 22 | 23 | $10,327 | $2,555 | 24.7% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 14 | 14 | $7,798 | $2,413 | 30.9% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2022 | 35 | 37 | $8,954 | $2,305 | 25.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 22 | 22 | $1,562 | $1,531 | 98.0% |
| 99219 | Initial hospital observation care per day, typically 50 minutes | Facility | 2022 | 12 | 12 | $5,904 | $1,362 | 23.1% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 11 | 17 | $4,080 | $814.82 | 20.0% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 18 | 19 | $1,121 | $232.94 | 20.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 228 | 757 | $274,791 | $76,615 | 27.9% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 103 | 669 | $154,539 | $40,499 | 26.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 151 | 151 | $59,947 | $22,514 | 37.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Office | 2021 | 21 | 171 | $39,501 | $9,076 | 23.0% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 26 | 31 | $24,397 | $7,897 | 32.4% |
| 99305 | Initial nursing facility visit, typically 35 minutes per day | Facility | 2021 | 56 | 60 | $25,920 | $6,773 | 26.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 49 | 80 | $19,760 | $5,738 | 29.0% |
| 90694 | Influenza virus vaccine, quadrivalent (aiiv4), inactivated, adjuvanted, preservative free, for injection into muscle, 0.5 ml dosage | Office | 2021 | 56 | 56 | $3,976 | $3,720 | 93.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 30 | 56 | $13,440 | $3,513 | 26.1% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2021 | 42 | 45 | $10,890 | $2,896 | 26.6% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 21 | 21 | $11,571 | $2,467 | 21.3% |
| 99495 | Transitional care management services, moderately complexity, requiring face-to-face visits within 14 days of discharge | Office | 2021 | 14 | 14 | $7,798 | $2,364 | 30.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 17 | 18 | $8,082 | $1,943 | 24.0% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 26 | 28 | $7,140 | $1,785 | 25.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 65 | 65 | $2,275 | $1,269 | 55.8% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 11 | 11 | $4,917 | $1,166 | 23.7% |
| 99318 | Nursing facility annual assessment, typically 30 minutes | Office | 2021 | 13 | 13 | $4,147 | $1,090 | 26.3% |
About Dr. Smitha Gubbi, MD
Dr. Smitha Gubbi, MD is a Family Medicine healthcare provider based in Bridgewater, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/06/2006. The National Provider Identifier (NPI) number assigned to this provider is 1275620650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Smitha Gubbi, MD has received a total of $8,058 in payments from pharmaceutical and medical device companies, with $1,758 received in 2024. These payments were reported across 553 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($8,017).
As a Medicare-enrolled provider, Gubbi has provided services to 4,445 Medicare beneficiaries, totaling 9,008 services with total Medicare billing of $753,527. Data is available for 4 years (2020–2023), covering 76 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Bridgewater, NJ
- Active Since 10/06/2006
- Last Updated 10/07/2016
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1275620650
Products in Payments
- FARXIGA (Drug) $481.46
- Ozempic (Drug) $383.91
- REXULTI (Drug) $338.06
- XIFAXAN (Drug) $331.65
- XARELTO (Drug) $325.85
- Cologuard Collection Kit (Device) $247.77
- BREZTRI (Drug) $191.75
- Rybelsus (Drug) $191.53
- TOUJEO (Drug) $182.30
- JARDIANCE (Drug) $173.04
- JANUVIA (Drug) $168.57
- SOLIQUA (Drug) $162.13
- Tresiba (Drug) $160.97
- ENTRESTO (Drug) $156.56
- Victoza (Drug) $151.60
- INVOKANA (Drug) $149.96
- Livalo (Drug) $147.13
- TRADJENTA (Drug) $132.92
- Veozah (Drug) $126.33
- Prolia (Biological) $123.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Bridgewater
Colleen Little, D.o, D.O
Family Medicine — Payments: $2,114
Mitchell Chasin, M.d, M.D
Family Medicine — Payments: $1,775
Dr. Jeanne Mitterando, M.d, M.D
Family Medicine — Payments: $1,210
Dr. Robert Flowers, D.o, D.O
Family Medicine — Payments: $1,077
Arlene Mccain, Md, MD
Family Medicine — Payments: $1,029
Dr. Christina Medrano, M.d, M.D
Family Medicine — Payments: $929.51